Monocyte toll-like receptor (TLR) 2 and 4 expression in chronic hepatitis C (HCV) and during therapy with pegylated interferon and ribavirin

被引：0
|
作者：
Testro, A. G. [1 ]
Patterson, S. [1 ]
Visvanathan, K. [2 ]
Lontos, S. [1 ]
Gow, P. J. [1 ]
Angus, P. W. [1 ]
机构：
[1] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia
[2] Monash Univ, Dept Med, Clayton, Vic 3800, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A286 / A286
页数：1
相关论文
共 50 条
  • [41] Pegylated interferon α-2b, ribavirin and amantadine for chronic hepatitis C
    Younossi, ZM
    McCullough, A
    Barnes, D
    Post, A
    Ong, J
    O'Shea, R
    Martin, LM
    Bringman, D
    Farmer, D
    Levinthal, G
    Mullen, KD
    Carey, WD
    Tavill, AS
    Ferguson, R
    Gramlich, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (05) : 970 - 975
  • [42] Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C
    Zobair M. Younossi
    Arthur C. McCullough
    David S. Barnes
    Anthony Post
    Janus P. Ong
    Robert O’shea
    Lisa M. Martin
    Diane Bringman
    Denise Farmer
    Gavin Levinthal
    Kevin D. Mullen
    William D. Carey
    Anthony S. Tavill
    Roy Ferguson
    Terry Gramlich
    Digestive Diseases and Sciences, 2005, 50 : 970 - 975
  • [43] The Association of Leptin Reduction With Efficacy of Pegylated Interferon and Ribavirin Therapy for Chronic Hepatitis C
    Kaneko, Fumihiko
    Yokomori, Hiroaki
    Kumagai, Naoki
    Toda, Kyoko
    Tsunematsu, Satoshi
    Tsuchimoto, Kanji
    Saito, Hidetsugu
    Hibi, Toshifumi
    GASTROENTEROLOGY, 2010, 138 (05) : S842 - S842
  • [44] Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy
    Taylor, Milton W.
    Tsukahara, Takuma
    Brodsky, Leonid
    Schaley, Joel
    Sanda, Corneliu
    Stephens, Matthew J.
    McClintick, Jeanette N.
    Edenberg, Howard J.
    Li, Lang
    Tavis, John E.
    Howell, Charles
    Belle, Steven H.
    JOURNAL OF VIROLOGY, 2007, 81 (07) : 3391 - 3401
  • [45] Adverse effects during the treatment with pegylated interferon and ribavirin in children with chronic hepatitis C
    Kowala-Piaskowska, Arleta
    Mozer-Lisewska, Iwona
    Figlerowicz, Magdalena
    Sluzewski, Wojciech
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (10) : 1095 - 1103
  • [46] Hepatic Toll-like receptor 3 expression in chronic hepatitis C genotype 1 correlates with treatment response to peginterferon plus ribavirin
    Yuki, N.
    Matsumoto, S.
    Kato, M.
    Yamaguchi, T.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (02) : 130 - 138
  • [47] Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
    Rodriguez-Lojo, R.
    Almagro, M.
    Barja, J. M.
    Pineyro, F.
    Perez-Varela, L.
    Del Pozo, J.
    Yebra-Pimentel, M. T.
    Fonseca, E.
    DERMATOLOGY RESEARCH AND PRACTICE, 2010, 2010
  • [48] Comparison of Pegylated interferon plus ribavirin with or without induction therapy for the treatment of chronic hepatitis C (HCV) non-responders.
    Bzowej, N
    Gish, R
    Wakil, A
    Brooks, L
    Shaffer, M
    Leung, J
    HEPATOLOGY, 2002, 36 (04) : 577A - 577A
  • [49] Fatal Neutropenic Enterocolitis during Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Virus Infection
    Kim, Ji Hun
    Jang, Jeong Won
    You, Chan Ran
    You, Si Young
    Jung, Mun Kyung
    Jung, Jin Hwan
    GUT AND LIVER, 2009, 3 (03) : 218 - 221
  • [50] Seizures during pegylated interferon and ribavirin therapy for chronic hepatitis C in the WIN-R Trial.
    Ahmed, F
    Rovner, D
    Jacobson, IM
    Albert, C
    Brand, M
    Cox, ME
    Fixelle, AM
    Herrera, J
    Rustgi, V
    Wasserman, RB
    Brown, RS
    Brass, C
    HEPATOLOGY, 2003, 38 (04) : 734A - 734A
12345